Compile Data Set for Download or QSAR
Report error Found 160 Enz. Inhib. hit(s) with all data for entry = 11841
TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652214(US11905306, No. 1)
Affinity DataEC50:  5.07E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652214(US11905306, No. 1)
Affinity DataEC50:  5.81E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652215(US11905306, No. 2)
Affinity DataEC50:  1.46E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652215(US11905306, No. 2)
Affinity DataEC50:  2.55E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652216(US11905306, No. 3)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652216(US11905306, No. 3)
Affinity DataEC50:  1.16E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652217(US11905306, No. 4)
Affinity DataEC50:  1.39E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652217(US11905306, No. 4)
Affinity DataEC50:  1.50E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652218(US11905306, No. 5)
Affinity DataEC50:  2.14E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652218(US11905306, No. 5)
Affinity DataEC50:  3.89E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652219(US11905306, No. 6)
Affinity DataEC50:  920nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652219(US11905306, No. 6)
Affinity DataEC50:  1.01E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652220(US11905306, No. 7)
Affinity DataEC50:  160nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652220(US11905306, No. 7)
Affinity DataEC50:  260nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652221(US11905306, No. 8)
Affinity DataEC50:  470nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652221(US11905306, No. 8)
Affinity DataEC50:  940nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652222(US11905306, No. 9)
Affinity DataEC50:  210nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652222(US11905306, No. 9)
Affinity DataEC50:  260nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652223(US11905306, No. 10)
Affinity DataEC50:  4.89E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652223(US11905306, No. 10)
Affinity DataEC50:  6.52E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652224(US11905306, No. 11)
Affinity DataEC50:  840nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652224(US11905306, No. 11)
Affinity DataEC50:  1.07E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652225(US11905306, No. 12)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652225(US11905306, No. 12)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652226(US11905306, No. 13)
Affinity DataEC50:  7.94E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652226(US11905306, No. 13)
Affinity DataEC50:  8.25E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652227(US11905306, No. 14)
Affinity DataEC50:  1.05E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652227(US11905306, No. 14)
Affinity DataEC50:  1.06E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652228(US11905306, No. 15)
Affinity DataEC50:  9.71E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652228(US11905306, No. 15)
Affinity DataEC50:  7.81E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652229(US11905306, No. 16)
Affinity DataEC50:  750nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652229(US11905306, No. 16)
Affinity DataEC50:  1.28E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652230(US11905306, No. 17)
Affinity DataEC50:  2.37E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652230(US11905306, No. 17)
Affinity DataEC50:  610nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652231(US11905306, No. 18)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652231(US11905306, No. 18)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652232(US11905306, No. 19)
Affinity DataEC50:  2.19E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652232(US11905306, No. 19)
Affinity DataEC50:  3.92E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652233(US11905306, No. 20)
Affinity DataEC50:  2.12E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652233(US11905306, No. 20)
Affinity DataEC50:  1.17E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652234(US11905306, No. 21)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652234(US11905306, No. 21)
Affinity DataEC50:  320nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652235(US11905306, No. 22)
Affinity DataEC50:  1.30E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652235(US11905306, No. 22)
Affinity DataEC50:  1.87E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652236(US11905306, No. 23)
Affinity DataEC50:  1.74E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652236(US11905306, No. 23)
Affinity DataEC50:  2.44E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652237(US11905306, No. 24)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652237(US11905306, No. 24)
Affinity DataEC50: >3.00E+4nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(SARS-CoV)
Southern Research Institute

US Patent
LigandPNGBDBM652238(US11905306, No. 25)
Affinity DataEC50:  520nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Southern Research Institute

US Patent
LigandPNGBDBM652238(US11905306, No. 25)
Affinity DataEC50:  1.09E+3nMAssay Description:Vero E6 cells were selected for expression of the SARS CoV receptor (ACE2; angiotensin-converting enzyme 2) was used for the CPE assay. Cells were gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 160 total ) | Next | Last >>
Jump to: